An educational session with Dr. Tomas Lobe on where the peptide industry stands today, where it's heading, and what practitioners should be watching.
Dr. Tomas Lobe, MD, FACS
Pediatric Surgeon · Regenerative Medicine · University of Illinois at Chicago
This is the inaugural session of Speak to an Expert, an educational series hosted by Path Peptides for the clinicians and practitioners who use our products. The series brings in outside experts to share their perspective on the peptide industry. It's not a product pitch or a brand session. It's industry education from people who know the space.
In this first session, Dr. Tomas Lobe will share his perspective on where the peptide industry stands today, where it's heading, what practitioners should be paying attention to, and the standards that will define the next phase. Abel from Path will moderate and open up a live Q&A so you can bring your questions directly to Dr. Lobe.
Independent expert perspectives on the industry, not product or brand content
Valid NPI required. This session is designed for clinicians who work with peptide protocols
20 to 30 minutes of moderated Q&A so you can ask Dr. Lobe directly
Can't make it live? Request access to the recording after the session
Five areas Dr. Lobe will address in this session, followed by a moderated live Q&A.
01
The current landscape
Where the peptide industry stands today and the forces shaping its direction.
02
What to watch
What practitioners should be paying attention to as the regulatory and sourcing landscape shifts.
03
Standards for the next phase
The quality and compliance standards that will define which suppliers earn practitioner trust going forward.
04
Clinical perspective
How Dr. Lobe thinks about peptide protocols in regenerative medicine and what informs those decisions.
05
Live Q&A with Dr. Tomas Lobe
20 to 30 minutes of moderated questions. Abel from Path moderates. Bring anything you've been sitting on about the peptide industry.
MD, FACS · Pediatric Surgeon · Regenerative Medicine Specialist · Professor of Clinical Surgery, University of Illinois at Chicago
Dr. Lobe has spent over four decades at the intersection of academic surgery and regenerative medicine. He served as Chief of Pediatric Surgery at St. Jude Children's Research Hospital for 20 years, where he trained over 40 surgeons and helped pioneer minimally invasive and robotic surgical techniques for pediatric care.
His career spans positions at the University of Texas Medical Branch, Shriner's Burns Hospital, and the University of Tennessee Health Sciences Center. He is currently a Professor of Clinical Surgery at the University of Illinois at Chicago and runs Regenevéda, a regenerative medicine practice with locations in Chicago, Beverly Hills, and New York City.
His practice focuses on advanced cellular therapy, hormone optimization, and peptide protocols. He brings a perspective grounded in both surgical rigor and decades of clinical application.
Monday, June 1, 2026. Free for licensed healthcare practitioners. Valid NPI required.
Recording available by request after the session.
Eligibility. This webinar is intended exclusively for licensed healthcare practitioners. Registration requires a valid NPI number and is subject to verification. Path Peptides products are sold for in-office practitioner use only and are not available to the general public.
Educational scope. The Speak to an Expert series is intended for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Content reflects independent expert perspectives on the peptide industry and is not a product or brand promotion. Clinical decisions should be made by the treating provider based on individual patient circumstances. Statements made by presenters reflect their professional opinions and do not represent FDA-approved indications.
Recording & data consent. By registering, you consent to receive emails related to this webinar and the Speak to an Expert practitioner series. The session will be recorded; attendee video and audio will not be captured unless explicitly enabled. You may unsubscribe at any time.
Path Peptides products are provided for research and educational purposes only. Not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the Food and Drug Administration.